Top Markets
Coin of the day
IDL Diagnostics AB (publ) IDL Diagnostics AB (publ)

IDL Diagnostics AB (publ)

IDLDX
Rankning i aktier #32452
Specializing in in vitro diagnostics (IVD), IDL Diagnostics AB (publ) develops... Specializing in in vitro diagnostics (IVD), IDL Diagnostics AB (publ) develops and markets diagnostic tests aimed at detecting cancer and bacterial infections within the Swedish market. Its product portfolio includes UBC Rapid, a point-of-care solution for both diagnosing and tracking bladder cancer; AroCell TK 210 ELISA, utilized as a biomarker for identifying tumor cells; and TUBEX TF, an in vitro diagnostic tool for pinpointing acute typhoid fever. Formerly operating as AroCell AB (publ), the company is scheduled to adopt the name IDL Diagnostics AB (publ) in May 2025. Established in 2000, its operations are headquartered in Stockholm, Sweden.
Aktiekurs
$0.04367217
Senast synkroniserad: 2026-08-17
Marknadsvärde
$10.06M
Förändring (1 dag)
3.99%
Förändring (1 år)
-26.77%
Land
SE
Handel IDL Diagnostics AB (publ) (IDLDX)

Kategori

Historik för aktiesplit för IDL Diagnostics AB (publ) (IDLDX)
Aktien IDL Diagnostics AB (publ) (symbol: IDLDX) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 18, 2026.
En IDLDX-aktie köpt före Aug 18, 2026 motsvarar nu 0 IDLDX-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
8 x34
US
7 x47
US
0 -
CN
0 -
US
4 x15
US